Simultaneous qualitative and quantitative analysis of counterfeit and unregistered medicines using Raman spectroscopy

被引:24
作者
Fraser, Sara J. [1 ]
Oughton, James [2 ]
Batten, William A. [3 ,4 ]
Clark, Austina S. S. [5 ]
Schmierer, David M. [3 ]
Gordon, Keith C. [1 ]
Strachan, Clare J. [3 ,6 ]
机构
[1] Univ Otago, Dept Chem, MacDiarmid Inst Adv Mat & Nanotechnol, Dunedin 9016, New Zealand
[2] Medsafe, Minist Hlth, Auckland, New Zealand
[3] Univ Otago, Sch Pharm, Dunedin 9016, New Zealand
[4] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England
[5] Univ Otago, Dept Math & Stat, Dunedin 9016, New Zealand
[6] Univ Helsinki, Fac Pharm, Div Pharmaceut Technol, Helsinki, Finland
关键词
counterfeit; preprocessing; classification; tadalafil; Raman; ANTIMALARIAL TABLETS; IDENTIFICATION; COMBINATION; SILDENAFIL; TADALAFIL; ECSTASY; NIR;
D O I
10.1002/jrs.4344
中图分类号
O433 [光谱学];
学科分类号
070207 [光学];
摘要
Raman spectroscopy was used to classify a group of seized counterfeit medications associated with erectile dysfunction. Using appropriate data preprocessing, principal component analysis and the classification method soft independent modelling of class analogy (SIMCA), it was possible to classify genuine from unregistered generic and counterfeit Cialis (R) batches. However, SIMCA did not effectively classify samples on the basis of their active pharmaceutical ingredient (API). Partial least squares discriminant analysis, principal component regression and support vector machines effectively distinguished between the API of the samples but were unable to correctly distinguish all samples as genuine or generic/counterfeit. This study highlights the importance of choosing the correct preprocessing procedures and classification method for the data set. Despite diverse tablet contents in addition to the drug, it was possible to quantify the levels of drug in the medicines as high, medium or low (within +/- 20mgg(-1) tablet concentration). Overall, the potential for Raman spectroscopy combined with multivariate analysis for qualitative and semiquantitative analysis of counterfeit medicines was demonstrated, and the approach may be used to determine the potential level of harm in counterfeit medicines on the basis of API identity and amount. Copyright (c) 2013 John Wiley & Sons, Ltd.
引用
收藏
页码:1172 / 1180
页数:9
相关论文
共 31 条
[1]
Abe S, 2010, ADV PATTERN RECOGNIT, P331, DOI 10.1007/978-1-84996-098-4_7
[2]
DEATH FOR SALE - A STUDY OF DRUG POISONING AND DEATHS IN NIGERIA [J].
ALUBO, SO .
SOCIAL SCIENCE & MEDICINE, 1994, 38 (01) :97-103
[3]
Quality analytics of internet pharmaceuticals [J].
Baert, B. ;
De Spiegeleer, B. .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2010, 398 (01) :125-136
[4]
Beebe K.R., 1998, CHEMOMETRICS PRACTIC
[5]
Composition profiling of seized ecstasy tablets by Raman spectroscopy [J].
Bell, SEJ ;
Burns, DT ;
Dennis, AC ;
Matchett, LJ ;
Speers, JS .
ANALYST, 2000, 125 (10) :1811-1815
[6]
Rapid analysis of ecstasy and related phenethylamines in seized tablets by Raman spectroscopy [J].
Bell, SEJ ;
Burns, DT ;
Dennis, AC ;
Speers, JS .
ANALYST, 2000, 125 (03) :541-544
[7]
Identification of pharmaceutical excipients using NIR spectroscopy and SIMCA [J].
Candolfi, A ;
De Maesschalck, R ;
Massart, DL ;
Hailey, PA ;
Harrington, ACE .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1999, 19 (06) :923-935
[8]
Determinaton of sildenafil citrate and related substances in the commercial products and tablet dosage form using HPLC [J].
Daraghmeh, N ;
Al-Omari, M ;
Badwan, AA ;
Jaber, AMY .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2001, 25 (3-4) :483-492
[9]
Detection of Lipitor® counterfeits:: A comparison of NIR and Raman spectroscopy in combination with chemometrics [J].
de Peinder, P. ;
Vredenbregt, M. J. ;
Visser, T. ;
de Kaste, D. .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2008, 47 (4-5) :688-694
[10]
Detection of counterfeit Viagra® with Raman spectroscopy [J].
de Veij, Marleen ;
Deneckere, Annelien ;
Vandenabeele, Peter ;
de Kaste, Dries ;
Moens, Luc .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2008, 46 (02) :303-309